
Poll results: What pipeline presbyopia treatment are you most looking forward to?
See our latest poll results
Optometry Times® polled our audience with the following question from October 22, 2021 to November 5, 2021:
The poll appeared on
81 ODs responded, in total. Of these:
- 1 responded "Orasis CSF-1"
- 5 responded "Allergan AGN-190584 drop"
- 3 responded "Eyenovia MicroLine drop"
- 1 responded "Presbyopia Therapies PRX-100"
- 2 responded "Ocuphire Pharma Nyxol"
- 69 responded "Visus Therapeutics Brimochol"
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.


















































.png)


